Monopar Therapeutics Inc.
25.46
0.48 (1.92%)
At close: Jan 15, 2025, 2:25 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income -8.83M -10.54M -9.13M -6.51M -4.32M -3.40M -16.60M -1.19M -688.56K
Interest Income 429.04M 21.24K 24.02K 81.90K 98.89K 103.22K 48.26K 7.23K 1.25K
Pretax Income -8.40M -10.52M -9.10M -6.30M -4.22M -3.30M -16.55M -1.19M -687.31K
Net Income -8.40M -10.49M -9.08M -6.22M -4.13M -3.23M -16.55M -1.19M -687.31K
Selling & General & Admin 3.23M 2.95M 2.63M 2.44M 2.36M 1.63M 1.17M 912.47K 587.08K
Research & Development 5.60M 7.59M 6.49M 4.07M 1.97M 1.77M 15.44M 280.36K 101.49K
Other Expenses n/a n/a n/a n/a n/a n/a 14.50M n/a n/a
Operating Expenses 8.83M 10.54M 9.13M 6.51M 4.32M 3.40M 16.60M 1.19M 688.56K
Interest Expense n/a n/a n/a n/a n/a 103.22K 48.26K 7.23K n/a
Selling & Marketing Expenses -3.23B n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 8.83M 10.54M 9.13M 6.51M 4.32M 3.40M 16.60M 1.19M 688.56K
Income Tax n/a -21.24K -24.02K -81.90K -98.89K -71.61K -2.10M 800.00 -688.56K
Shares Outstanding (Basic) 14.51M 12.72M 12.47M 10.96M 10.59M 10.42M 10.42M 10.42M 10.59M
Shares Outstanding (Diluted) 14.51M 12.72M 12.47M 10.96M 10.59M 10.42M 10.42M 10.42M 10.59M
EPS (Basic) -0.58 -0.83 -0.73 -0.57 -0.39 -0.31 -1.59 -0.11 -0.06
EPS (Diluted) -0.58 -0.83 -0.73 -0.57 -0.39 -0.31 -1.59 -0.11 -0.06
EBITDA 429.04K n/a n/a n/a n/a n/a -16.55M 8.03K 1.25K
Depreciation & Amortization 8.83M 10.54M 9.13M 6.51M 4.32M 3.33M 2.10M 1.19M 688.56K

Create Price Alert on MNPR

Your price alert will notify you when the stock price is above 25.46.

Add to Watchlist